inhibit, Inhibitor, Bacterial, CB1, CB, Cannabinoid Receptor, CannabinoidReceptor, SR 141716A, SR 151716A, Rimonabant, Rimonabant hydrochloride, Rimonabant Hydrochloride
Rimonabant hydrochloride (SR 141716A) is a selective, high-affinity antagonist of the central cannabinoid CB1 receptor. It is widely used in metabolic and obesity research to investigate the endocannabinoid systems role in appetite and energy balance, both in vitro and in vivo.